Africa losing opportunities to reduce poverty because of ‘dysfunctional’ GM debate

Opportunities to enhance crop yields and reduce poverty in Africa are being lost because of a “polarised public debate” on the continent, according to a report released 21 July by international policyinstitute Chatham House.

Genetic modification (GM) research projects remain stuck at the field trial stage due to governments’ fears keeping the technology from African farmers, it says. This “deadlock” of continual field trials has allowed African governments to appease both sides of the GM debate: proponents are pleased research is done, whereas opponents are satisfied that research has not led to products on the market, the report says.

“Many of the opponents of GM crops are not interested in engagement or understanding. They want to eliminate the technology altogether,” says Calestous Juma, an international development expert at Harvard Kennedy School, United States.

In many African countries, the report says, governments face political damage for being perceived to be too pro-GM. Policymakers are reluctant to release biotechnologies due to fears of media campaigns or a backlash from civil society, it adds. The most important improvements needed, the report notes, are engaging farmers in research to understand their needs and making sure this research translates into impact.

Read the full, original article: GM’s potential in Africa impeded by ‘dysfunctional debate’

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-07-09-at-1.09.25-PM
Anti-vaccine myths rattle health care
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot 2026-07-28 at 3.22
Hidden hunger: Climate change is speeding up the decline of important nutrients in our food
Screenshot 2026-07-22 at 1.38
Viewpoint: Are the U.S. and Europe headed towards a repudiation of agricultural biotechnology red tape?
Screenshot 2026-07-28 at 3.03
What is cyberchondria?
Screenshot 2026-07-28 at 2.04
Viewpoint: How AI supercharges conspiracy theories and oversimplifications to distort online health information
organic scaled
Facts & Fallacies podcast: Organic food cuts pesticide exposure? A response to Dr. Rhonda Patrick
png-terrace-Farm-asia
Europe’s tentative embrace of agricultural gene editing could revolutionize food production and health in Asia
ChatGPT-Image-May-26-2026-11_51_01-AM
Viewpoint: RFK, Jr.’s depressingly misguided (and litigator-funded) crusade against antidepressants
ChatGPT-Image-Jul-9-2026-11_33_49-AM
Viewpoint: High-dose resveratrol supplements to extend health and life? Don’t waste your money.
Screenshot-2026-07-27-at-3.23.14-PM
Prioritizing AI, robotics, and nuclear energy: Trump administration is guiding research funding away from independent universities to private companies
Screenshot 2026-07-28 at 3.43
Fat cat? GLP-1 weight loss drugs for animals are on the horizon
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.